Article Type
Changed
Fri, 01/04/2019 - 11:12
Display Headline
Evolving therapeutic strategies maintain clinical momentum in melanoma

The past 5 years have witnessed a watershed moment in the management of metastatic melanoma. The successes of molecularly targeted and immune-based therapies have transformed it from an aggressively lethal malignancy into one that is readily treatable. Here, we discuss continued efforts to find new therapies and broaden the clinical impact of existing options to maintain the unprecedented momentum of improving patient outcomes.

 

Click on the PDF icon at the top of this introduction to read the full article.

 

Article PDF
Issue
The Journal of Community and Supportive Oncology - 14(6)
Publications
Topics
Page Number
280-286
Legacy Keywords
melanoma, BRAF, MAPK signaling, immunotherapy, vemurafenib, dabrafenib, ipilimumab
Sections
Article PDF
Article PDF

The past 5 years have witnessed a watershed moment in the management of metastatic melanoma. The successes of molecularly targeted and immune-based therapies have transformed it from an aggressively lethal malignancy into one that is readily treatable. Here, we discuss continued efforts to find new therapies and broaden the clinical impact of existing options to maintain the unprecedented momentum of improving patient outcomes.

 

Click on the PDF icon at the top of this introduction to read the full article.

 

The past 5 years have witnessed a watershed moment in the management of metastatic melanoma. The successes of molecularly targeted and immune-based therapies have transformed it from an aggressively lethal malignancy into one that is readily treatable. Here, we discuss continued efforts to find new therapies and broaden the clinical impact of existing options to maintain the unprecedented momentum of improving patient outcomes.

 

Click on the PDF icon at the top of this introduction to read the full article.

 

Issue
The Journal of Community and Supportive Oncology - 14(6)
Issue
The Journal of Community and Supportive Oncology - 14(6)
Page Number
280-286
Page Number
280-286
Publications
Publications
Topics
Article Type
Display Headline
Evolving therapeutic strategies maintain clinical momentum in melanoma
Display Headline
Evolving therapeutic strategies maintain clinical momentum in melanoma
Legacy Keywords
melanoma, BRAF, MAPK signaling, immunotherapy, vemurafenib, dabrafenib, ipilimumab
Legacy Keywords
melanoma, BRAF, MAPK signaling, immunotherapy, vemurafenib, dabrafenib, ipilimumab
Sections
Citation Override
JCSO 2016;14:280-286
Disallow All Ads
Alternative CME
Article PDF Media